Literature DB >> 19112735

The Chikungunya epidemic in Italy and its repercussion on the blood system.

Giancarlo Maria Liumbruno1, Deanna Calteri, Kyriakoula Petropulacos, Andrea Mattivi, Claudio Po, Pierluigi Macini, Ivana Tomasini, Paolo Zucchelli, Anna Rita Silvestri, Vittorio Sambri, Simonetta Pupella, Liviana Catalano, Vanessa Piccinini, Gabriele Calizzani, Giuliano Grazzini.   

Abstract

BACKGROUND: The Chikungunya virus (CHIKV) is transmitted by Aedes mosquitoes and recently caused a massive epidemic on La Réunion Island, in the Indian Ocean. Between July and September 2007 it caused the first autochthonous epidemic outbreak in Europe, in the Region of Emilia-Romagna in the north-east of Italy.
MATERIALS AND METHODS: After the first reports of an unusually high number of patients with a febrile illness of unknown origin in two contiguous villages, an outbreak investigation was carried out to identify the primary source of infection, the modes of transmission and the dynamics of the epidemic. An active surveillance system was also implemented. Laboratory diagnosis was performed through serology and polymerase chain reaction (PCR) analysis. Blood donation was discontinued in the areas involved from September to October 2007 and specific precautionary blood safety and self-sufficiency measures were adopted by the regional health and blood authorities and the National Blood Centre. An estimate method to early assess the risk of viraemic blood donations by asymptomatic donors was developed, as a tool for "pragmatic" risk assessment and management, aiming at providing a reliable order of magnitude of the mean risk of CHIKV transmission through blood transfusion.
RESULTS: Two hundred and seventeen cases of CHIKV infection were identified between 4th July and 28th September. The disease was fairly mild in most of the cases. The precautionary measures adopted in the blood system caused a considerable reduction of the collection of blood components and of the delivery of plasma to the pharmaceutical industry for contract manufacturing. The estimated risk of CHIKV transmission through blood transfusion peaked in the third week of August.
CONCLUSION: ACHIKV epidemic poses considerable problems for public health authorities, who not only need good routine programmes of vector control and epidemiological surveillance but also local and national emergency plans to sustain the blood supply, so as to promptly deal with the potentially severe effects of an epidemic outbreak, especially when affected areas locally require a significant blood inventory and at the same time represent a critical resource for other areas depending on external supplies of blood components.

Entities:  

Mesh:

Year:  2008        PMID: 19112735      PMCID: PMC2626913          DOI: 10.2450/2008.0016-08

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  38 in total

1.  The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic.

Authors:  R W ROSS
Journal:  J Hyg (Lond)       Date:  1956-06

2.  [Aedes albopictus in Italy: an underestimated health problem].

Authors:  R Romi
Journal:  Ann Ist Super Sanita       Date:  2001       Impact factor: 1.663

3.  Chikungunya and dengue: a case of mistaken identity?

Authors:  D E Carey
Journal:  J Hist Med Allied Sci       Date:  1971-07       Impact factor: 2.088

4.  Chikungunya disease.

Authors:  J J Deller; P K Russell
Journal:  Am J Trop Med Hyg       Date:  1968-01       Impact factor: 2.345

5.  Virological investigation of cases with neurological complications during the outbreak of haemorrhagic fever in Calcutta.

Authors:  S N Chatterjee; S K Chakravarti; A C Mitra; J K Sarkar
Journal:  J Indian Med Assoc       Date:  1965-09-16

6.  Viraemia in patients with naturally acquired dengue infection.

Authors:  D J Gubler; W Suharyono; R Tan; M Abidin; A Sie
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

7.  Dengue in the early febrile phase: viremia and antibody responses.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

8.  Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City.

Authors:  Brad J Biggerstaff; Lyle R Petersen
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

9.  A serological study of Chikungunya virus transmission in Yogyakarta, Indonesia: evidence for the first outbreak since 1982.

Authors:  Kevin R Porter; Ratna Tan; Yunry Istary; Wuryadi Suharyono; Susana Widjaja; Chairin Ma'Roef; Erlin Listiyaningsih; Herman Kosasih; Linda Hueston; James McArdle; Mohammad Juffrie
Journal:  Southeast Asian J Trop Med Public Health       Date:  2004-06       Impact factor: 0.267

10.  Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002.

Authors:  Brad J Biggerstaff; Lyle R Petersen
Journal:  Transfusion       Date:  2003-08       Impact factor: 3.157

View more
  45 in total

Review 1.  Red blood cell storage: the story so far.

Authors:  Angelo D'Alessandro; Giancarlo Liumbruno; Giuliano Grazzini; Lello Zolla
Journal:  Blood Transfus       Date:  2010-04       Impact factor: 3.443

Review 2.  Zika virus and the never-ending story of emerging pathogens and transfusion medicine.

Authors:  Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-11-05       Impact factor: 3.443

3.  Blood safety and zoonotic emerging pathogens: now it's the turn of Zika virus!

Authors:  Massimo Franchini; Claudio Velati
Journal:  Blood Transfus       Date:  2015-11-05       Impact factor: 3.443

4.  West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system.

Authors:  Giuliano Grazzini; Giancarlo Maria Liumbruno; Simonetta Pupella; Anna Rita Silvestri; Vanda Randi; Nadia Pascarelli; Paolo Zucchelli; Antonino Di Caro; Nadir Spataro; Erika D'Angelo; Vittorio Sambri
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

Review 5.  The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.

Authors:  Gabriele Calizzani; Stefania Vaglio; Fabio Candura; Samantha Profili; Monica Lanzoni; Karen Cristiano; Maria Rita Tamburrini; Giuliano Grazzini; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 6.  Emerging Pathogens - How Safe is Blood?

Authors:  Michael Schmidt; Wolf-Jochen Geilenkeuser; Walid Sireis; Erhard Seifried; Kai Hourfar
Journal:  Transfus Med Hemother       Date:  2013-12-27       Impact factor: 3.747

Review 7.  Classic and alternative red blood cell storage strategies: seven years of "-omics" investigations.

Authors:  Lello Zolla; Angelo D'alessandro; Sara Rinalducci; Gian Maria D'amici; Simonetta Pupella; Stefania Vaglio; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

Review 8.  Hepatitis E: an old infection with new implications.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Maria Bianchi; Gabriele Calizzani; Fabio Candura; Liviana Catalano; Blandina Farina; Monica Lanzoni; Vanessa Piccinini; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

9.  Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light.

Authors:  Konstantin A Tsetsarkin; Adam Sampson-Johannes; Lynette Sawyer; John Kinsey; Stephen Higgs; Dana L Vanlandingham
Journal:  Am J Trop Med Hyg       Date:  2013-03-25       Impact factor: 2.345

10.  Climate change could threaten blood supply by altering the distribution of vector-borne disease: an Australian case-study.

Authors:  Hilary J Bambrick; Rosalie E Woodruff; Ivan C Hanigan
Journal:  Glob Health Action       Date:  2009-12-10       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.